Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Yesterday, Nov. 14, 2013, 154 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $292.50 to $467,462,888.00. Highlighted Stocks Traded by Insiders: WellCare Health Plans (WCG) - FREE Research Report Cunningham Alexander R. who is Director at WellCare Health Plans sold 54,305 shares at $67.27 on Nov. 14, 2013. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 54,305 share transaction. The shares most recently traded at $69.08, up $1.81, or 2.62% since the insider transaction. The average volume for WellCare Health Plans has been 513,500 shares per day over the past 30 days. WellCare Health Plans has a market cap of $2.9 billion and is part of the health care sector and health services industry. Shares are up 38.57% year to date as of the close of trading on Thursday. WellCare Health Plans, Inc. provides managed care services for government-sponsored health care programs in the United States. The company has a P/E ratio of 16.4. Currently there are 5 analysts that rate WellCare Health Plans a buy, no analysts rate it a sell, and 4 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on WCG - FREETheStreet Quant Ratings rates WellCare Health Plans as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full WellCare Health Plans Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.